Plasma triglyceride and coronary heart disease

Cited by (696)

Items 301–400 of 696

1. High lipid levels and coronary disease in women in Göteborg—outcome and secular trends: a prospective 19 year follow-up in the BEDAstudy
   S Johansson · 2003 · European Heart Journal
2. The rise of the plasma lipid concentration elicited by dietary sodium chloride restriction in Wistar rats is due to an impairment of the plasma triacylglycerol removal rate
   Sérgio Catanozi, Jussara C. Rocha, Edna Regina Nakandakare, Marisa Passarelli, C.H. Mesquita, Alexandre A. da Silva, Miriam Sterman Dolnikoff, L.M. Harada, Eder C.R. Quintão, Joel Cláudio Heimann · 2001 · Atherosclerosis
3. VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor
   Lennart Nilsson, Mats E. Gåfvels, Leena Musakka, Katharina Ensler, Dudley K. Strickland, Bo Angelin, Anders Hamsten, Per Olof Eriksson · 1999 · Journal of Lipid Research
4. Diet and plasma lipids in women. II. Macronutrients and plasma triglycerides, high-density lipoprotein, and the ratio of total to high-density lipoprotein cholesterol in women: The Framingham Nutrition Studies
   Lillian M. Sonnenberg, Paula A. Quatromoni, DAVID R. GAGNON, L. Adrienne Cupples, MARY M. FRANZ, José María Ordovás, Peter W.F. Wilson, Ernst J. Schaefer, Barbara E. Milien · 1996 · Journal of Clinical Epidemiology
5. Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype
   Matthias Orth, Sabine Wahl, Monika Hanisch, I. Friedrich, Heinrich Wieland, Claus H. Luley · 1996 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
6. Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia
   Cesar S. Recto, Stella Acosta, Adrian Sandra Dobs · 2000 · Clinical Cardiology
7. Insulin Resistance, Compensatory Hyperinsulinemia, and Coronary Heart Disease: Syndrome X Revisited
   Gerald M. Reaven · 2001 · Comprehensive physiology
8. Changes in serum lipids and platelet fatty acid composition following consumption of eggs enriched in alpha-linolenic acid (LnA)
   L.K. Ferrier, Linda J. Caston, Steve Leeson, Eli James Squires, Bernadette Celi, Lisa M. Black Thomas, Bruce John Holub · 1992 · Food Research International
9. High flux dialysis membranes improve plasma lipoprotein proffles in patients with end-stage renal disease
   Ira J. Goldberg, A. M. Kaufman, Valentina Lavarias, Teresa Vanni-Reyes, Nathan W. Levin · 1996 · Nephrology Dialysis Transplantation
10. Low-density lipoprotein subclasses: mechanisms of formation and modulation
    Bruce Arthur Griffin · 1997 · Proceedings of The Nutrition Society
11. Consenso de expertos sobre propuestas para la mejora del manejo de la dislipemia aterogénica
    Jesús Millán Núñez-Cortés, Juan Pedro‐Botet, Ángel Brea-Hernando, Ángel Díaz Rodríguez, Pedro González‐Santos, Antonio Hernández‐Mijares, Teresa Mantilla, Xavier Pintó, Rafael Simó · 2013 · Revista Española de Cardiología
12. Quantitative detection method of triglycerides in serum lipoproteins and serum-free glycerol by high-performance liquid chromatography
    Mitsuyo Okazaki, Norikazu Komoriya, Hitonobu Tomoike, Noriko Inoue, Shinichi Usui, Sekiko Itoh, Seijin Hosaki · 1998 · Journal of Chromatography B Biomedical Sciences and Applications
13. Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol
    Mikko Syvänne, Philippa J. Talmud, Steve Eric Humphries, Rachel M. Fisher, M. Rosseneu, Hannele Hilden, Marja‐Riitta Taskinen · 1997 · Journal of Lipid Research
14. Effects of NO-1886 (Ibrolipim), a Lipoprotein Lipase-Promoting Agent, on Gene Induction of Cytochrome P450s, Carboxylesterases, and Sulfotransferases in Primary Cultures of Human Hepatocytes
    Masuhiro Nishimura, Teruko Imai, Yujiro Morioka, Shunji Kuribayashi, Tetsuya Kamataki, Shinsaku Naito · 2004 · Drug Metabolism and Pharmacokinetics
15. Paclitaxel and platinum-based chemotherapy results in transient dyslipidemia in cancer patients
    Guoping Wang, Chao Su, Tao Yin · 2016 · Molecular and Clinical Oncology
16. Perfil lipídico e intensidade de doença aterosclerótica na síndrome coronariana aguda
    Rafaela Penalva, Marçal de Oliveira Huoya, Luís Cláudio Lemos Correia, Gílson Soares Feitosa, Ana Marice Teixeira Ladeia · 2008 · Arquivos Brasileiros de Cardiologia
17. Oxidised LDL, HDL cholesterol, LDL cholesterol levels in patients of coronary artery disease
    Joya Ghosh, Tarun Kumar Mishra, Y. N. Rao, S. K. Aggarwal · 2006 · Indian Journal of Clinical Biochemistry
18. Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE
    Jeffrey S. Cohn, Claudia Rodriguez, Hélène Jacques, Michel Tremblay, Jean Davignon · 2004 · Journal of Lipid Research
19. Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: Further evidence for a unique form of Metabolic Syndrome in HIV patients
    Catherine N. Vu, Raul Ruiz-Esponda, Eric Yang, Evelyn Chang, Baiba Kurins Gillard, Henry J. Pownall, Ron Cornelis Hoogeveen, Ivonne Coraza, Ashok Balasubramanyam · 2013 · Metabolism
20. Predictive Value of Remnant-like Particle Cholesterol as an Indicator of Coronary Artery Stenosis in Patients with Normal Serum Triglyceride Levels.
    Hiroshi Masuoka, Shigeru KAMEI, Morihiro Ozaki, Atsushi Kawasaki, Uichiro Shintani, Masaaki Ito, Takeshi Nakano · 2000 · Internal Medicine
21. Effects of a cardioselective β-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk
    Susanna Boquist, Giacomo Ruotolo, Mai-Lis Hellénius, Karin Danell-Toverud, Fredrik Karpe, Anders Hamsten · 1998 · Atherosclerosis
22. Correlation between mutations in p53 gene and protein expression in human lymphomas
    Beatriz Martínez–Delgado, Mercedes Robledo, Eva Arranz, Fernando Infantes, G Echezarreta, B Marcos, C. Sanz, Carmen Rivas, Javier J. Benitez · 1997 · American Journal of Hematology
23. Effects of raloxifene on lipid and lipoprotein levels in postmenopausal osteoporotic women with and without hypertriglyceridemia
    Thomas D. Dayspring, Yongming Qu, Cheryl A. Keech · 2006 · Metabolism
24. Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo
    Kalyane Bach‐Ngohou, Hassan Nazih, Françoise Nazih‐Sanderson, Yassine Zaïr, Didier Le Carrer, Michel Krempf, Jean‐Marie Bard · 2001 · International Journal of Obesity
25. High-Density Lipoprotein Cholesterol, Plasma Triglyceride, and Coronary Heart Disease: Pathophysiology and Management
    Wolfgang Patsch, Antonio M. Gotto · 1995 · Advances in pharmacology
26. Small LDL and Its Clinical Importance as a New CAD Risk Factor: A Female Case Study
    H. Robert Superko, Mary Nejedly, Brenda C. Garrett · 2002 · Progress in Cardiovascular Nursing
27. Post-prandial remnant lipids impair arterial compliance.
    P. Nestel, H. Shige, S. Pomeroy, M. Cehun, J. Chin-dusting · 2001 · Journal of the American College of Cardiology
28. Maximal post‐prandial triglyceride increase reflects post‐prandial hypertriglyceridaemia and is associated with the insulin resistance syndrome
    Basil G. Karamanos, Anastasia C. Thanopoulou, Demetra P. Roussi · 2001 · Diabetic Medicine
29. Lipoprotein Lipase Activator NO‐1886
    Weidong Yin, Kazuhiko Tsutsumi · 2003 · Cardiovascular Drug Reviews
30. Lipids, Apolipoproteins and Lipoproteins
    Daniel James Rader, H. Bryan Brewer · 1994 · Developments in cardiovascular medicine
31. Health Claims: Omega-3 Fatty Acids and Cardiovascular Disease
    Alexander Leaf · 2009 · Nutrition Reviews
32. Alterations of Serum Lipid and Inflammatory Cytokine Profiles in Patients with Coronary Heart Disease and Chronic Periodontitis: A Pilot Study
    Kashem Tang, Minkun Lin, Yun Wu, Fuhua Yan · 2011 · Journal of International Medical Research
33. Effect of somatostatin analog on high-fat diet-induced metabolic syndrome: Involvement of reactive oxygen species
    Wu Li, Yonghui Shi, Ruili Yang, Jue Cui, Ying Xiao, Bin Wang, Guowei Le · 2009 · Peptides
34. Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty.
    M Chester, L. Chen, Juan Carlos Kaski · 1995 · Heart
35. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy
    See Kwok, Peter L. Selby, Patrick McElduff, Ian Laing, Bharti Mackness, Mike Mackness, Hilary Prais, Janet Morgan, Allen P. Yates, Paul N. Durrington et al. · 2004 · Clinical Endocrinology
36. Insulin sensitivity in familial hypercholesterolemia
    Alfredo Quiñones Galvan, Donatella Santoro, Andrea Natali, Tiziana Sampietro, Claudio De Boni, Antonio Masoni, Giuseppe Buzzigoli, Eleuterio Ferrannini · 1993 · Metabolism
37. Systematic error of serum triglyceride measurements during three decades and the effect of fasting on serum triglycerides in population studies
    Jouko Sundvall, Tiina K. Laatikainen, Samu Hakala, Jaana Leiviskä, Georg Alfthan · 2008 · Clinica Chimica Acta
38. The role of HMG-CoA reductase inhibitors in the treatment of hyperlipidemia: a review of fluvastatin
    Jean Paul Deslypere · 1995 · Current Therapeutic Research
39. Syndrome X: Is one enough?
    Gerald M. Reaven · 1994 · American Heart Journal
40. Adipocyte beta-adrenoceptor sensitivity influences plasma lipid levels.
    Peter Arner, Hans Wahrenberg, Fredrik Lönnqvist, B. Angelin · 1993 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
41. Clinical lipidology at the end of the millennium
    Gilbert R. Thompson, Philip J. Barter · 1999 · Current Opinion in Lipidology
42. Clinical review 43: Treatment of hypertension: focus on prevention of coronary heart disease
    Gerald M. Reaven · 1993 · The Journal of Clinical Endocrinology & Metabolism
43. Metabolic risk factors for coronary heart disease: current and future prospects
    Peter W.F. Wilson · 1999 · Current Opinion in Cardiology
44. Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects
    Mikko Syvänne, Pia Pajunen, Juhani Kahri, Sanni Lahdenper, Christian Ehnholm, Markku S. Nieminen, Marja‐Riitta Taskinen · 2001 · Coronary Artery Disease
45. Apolipoproteins, Dyslipoproteinaemia and Premature Coronary Heart Disease
    Anders Hamsten · 1988 · Acta Medica Scandinavica
46. Remnant cholesterol as a risk factor for cardiovascular, cancer or other causes mortality: A competing risks analysis
    Caterina Bonfiglio, Carla Maria Leone, Liciana Vaz de Arruda Silveira, Rocco Guerra, Giovanni Misciagna, Maria Gabriella Caruso, Irene Bruno, Claudia Buongiorno, Angelo Campanella, Vito M.B. Guerra et al. · 2020 · Nutrition Metabolism and Cardiovascular Diseases
47. Apolipoprotein E and lipoprotein lipase reduce macrophage degradation of oxidized very-low-density lipoprotein (VLDL), but increase cellular degradation of native VLDL
    Shlomo Keidar, Marielle Kaplan, Mira Rosenblat, Gerald J. Brook, Michael Aviram · 1992 · Metabolism
48. The effects of long‐term anticonvulsive treatment on serum lipid profile
    Erdinç Yalçın, A Hassanzadeh, KHAYRYA MAWLUD · 1997 · Pediatrics International
49. Cholesterol and unsaturated fat diets influence lipid and glucose concentrations in rats
    Panayiotis N. Adamopoulos, Christakis M. Papamichael, Antonis Zampelas, Spyros D. Moulopoulos · 1996 · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology
50. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
    Simon W. Rabkin, M W Huff, C Newman, Dalice A Sim, S. George Carruthers · 1994 · Hypertension
51. The acute effects of a single very high dose of n−3 fatty acids on plasma lipids and lipoproteins in healthy subjects
    Niels Svaneborg, J. M. Møller, Erik Berg Schmidt, Kim Varming, Hans Henrik Lervang, J. Dyerberg · 1994 · Lipids
52. Does bicarbonated mineral water rich in sodium change insulin sensitivity of postmenopausal women?
    Stefanie Schoppen, Francisco José Sánchez-Muniz, M Pérez-Granados, J. A. Gómez-Gerique, Beatriz Sarriá, Santiago Navas‐Carretero, Ma Pilar Vaquero · 2007 · PubMed
53. Cerivastatin in the treatment of mixed hyperlipidemia: the right study
    Michel Farnier · 1998 · The American Journal of Cardiology
54. The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy
    M. John Chapman, Éric Bruckert · 1996 · Atherosclerosis
55. Ostial Lesions of Left Main and Right Coronary Arteries: Demographic and Angiographic Features
    Sirous Darabian, Ali Reza Amirzadegan, Hakimeh Sadeghian, Saeed Sadeghian, Ali Abbasi, Maria Raeesi · 2008 · Angiology
56. The impact of cranberry (Vaccinium macrocarpon) and cranberry products on each component of the metabolic syndrome: a review
    Nataly Simões Bandiera Thimoteo, Bruna Miglioranza Scavuzzi, Andréa Name Colado Simão, Isaías Dichi · 2017 · Nutrire
57. Over 80 Years and No Evidence of Coronary Heart Disease: Characteristics of a Survivor Group
    Angela J. Campbell, WENDY J. BUSBY, M. Clare Robertson · 1993 · Journal of the American Geriatrics Society
58. Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease
    Henry N. Ginsberg · 1999 · Current Cardiology Reports
59. Water Extract of Defatted Rice Bran Suppresses Visceral Fat Accumulation in Rats
    Kazuhiko Tsutsumi, Yoshiyuki Kawauchi, Yasunori Kondo, Yasuhide Inoue, Osamu Koshitani, Hideaki Kohri · 2000 · Journal of Agricultural and Food Chemistry
60. The BB-Paraoxonase Genotype Is Associated with Impaired Brachial Reactivity after Acute Hypertriglyceridemia in Healthy Subjects
    Giuseppe Paolisso, Daniela Manzella, Maria Rosaria Tagliamonte, Michelangela Barbieri, Raffaele Marfella, Guido Antonio Zito, Massimiliano Bonafè, Dario Giugliano, Claudio Franceschi, Michele Varricchio · 2001 · The Journal of Clinical Endocrinology & Metabolism
61. Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol
    Claes Held, Paul Hjemdahl, Nina Rehnqvist, Inge Björkander, Lennart Forslund, Ulf Brodin, Lars Berglund, B. Angelin · 1997 · Atherosclerosis
62. Clinical perspectives on primary and secondary prevention of coronary atherosclerosis
    PRAKASH C. DEEDWANIA · 1995 · Medical Clinics of North America
63. Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia
    B. F�ger, Heinz Drexel, Thomas Hopferwieser, G. Miesenb�ck, Andreas Ritsch, Monika Lechleitner, G. Tr�binger, Josef R. Patsch · 1994 · Journal of Molecular Medicine
64. Influence of fitness status on very—low-density lipoprotein subfractions and lipoprotein(a) in men and women
    Tom R Thomas, George G. Ziogas, William Stephen Harris · 1997 · Metabolism
65. Cardiovascular Risk Factors: Interactive Effects of Lipids, Coagulation and Fibrinolysis
    Ludvig N.W. Daae, Peter Kierulf, Sverre Landaas, Petter Urdal · 1993 · Scandinavian Journal of Clinical and Laboratory Investigation
66. Effects of lovastatin on the levels, structure, and atherogenicity of VLDL in patients with moderate hypertriglyceridemia.
    Sandra H. Gianturco, William A. Bradley, Satoshi Nozaki, Gloria Lena Vega, Scott M. Grundy · 1993 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
67. Perfil inflamatório, metabólico e lipídico na síndrome isquêmica aguda: relação com eventos intra e pós-hospitalares
    Elizabeth da Rosa Duarte, Lúcia Campos Pellanda, Vera Lúcia Portal · 2005 · Arquivos Brasileiros de Cardiologia
68. Altered skeletal muscle glucose transport and blood lipid levels in habitual cigarette smokers
    Rincón, Anna Krook, Galuska, Harriet Wallberg‐Henriksson, Juleen Rae Zierath · 1999 · Clinical Physiology
69. Oxidizability and subsequent cytotoxicity of chylomicrons to monocytic U937 and endothelial cells are dependent on dietary fatty acid composition
    Laurence Mabile, Robert Salvayre, Marie-José Bonnafé, Anne Nègre‐Salvayre · 1995 · Free Radical Biology and Medicine
70. Intestinal Fatty acid Absorption
    Yong Seok Ji, Xiaoming Li, Patrick Tso · 2009 · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry
71. Methods for Studying Rodent Intestinal Lipoprotein Production and Metabolism
    Alison B. Kohan, Philip N. Howles, Patrick Tso · 2012 · Current Protocols in Mouse Biology
72. Detection of quantitative trait loci affecting serum cholesterol, LDL, HDL, and triglyceride in pigs
    Muhammad Jasim Uddin, Do Ngoc Duy, Mehmet Ulaş Çınar, Dawit Tesfaye, Ernst Tholen, Heinz Juengst, Christian Looft, K. Schellander · 2011 · BMC Genetics
73. Effect of Cigarette Smoking on Serum Lipid Profile in Male Population of Udaipur
    Deepa Singh · 2016 · Biochemistry & Analytical Biochemistry
74. Atherosclerosis and Physical Activity
    Ali Al-Mamari · 2009 · Oman Medical Journal
75. Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia
    Genovefa D. Kolovou, Katherine K. Anagnostopoulou, Nektarios D. Pilatis, Klelia D. Salpea, Ioannis S. Hoursalas, Ilias Petropoulos, Helen I. Bilianou, Dennis V. Cokkinos · 2005 · Vascular Health and Risk Management
76. Long-term vitamin A does not produce clinically significant hypertriglyceridemia: results from CARET, the beta-carotene and retinol efficacy trial.
    Gilbert S. Omenn, Gary E. Goodman, Mark D. Thornquist, John D. Brunzell · 1994 · PubMed
77. Lipid profile variations in a group of healthy elderly and centenarians.
    Mariano Malaguarnera, Ignazio Giugno, P. Ruello, Maria Rosaria Rizzo, Maria Pia Panebianco, G Pistone, F.B. Tomasello · 1998 · PubMed
78. Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction
    Roberto Gambino, Luca Scaglione, Natalina Alemanno, Gianfranco Pagano, Maurizio Cassader · 1999 · Metabolism
79. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding
    Frits H.A.F. de Man, Femke de Beer, Arnoud van der Laarse, Hans Jansen, J.A. Gevers Leuven, John H. M. Souverijn, Ton F.F.P. Vroom, Selene C. M. Schoormans, Jean‐Charles Fruchart, Louis M. Havekes et al. · 2000 · Atherosclerosis
80. Macrophages take up triacylglycerol‐rich emulsions at a faster rate upon co‐incubation with native and modified LDL: An investigation on the role of natural chylomicrons in atherosclerosis
    Márcia D.T. Carvalho, L.M. Harada, Magnus Gidlund, Daniel F.J. Ketelhuth, Paulo Boschcov, Eder C.R. Quintão · 2001 · Journal of Cellular Biochemistry
81. Short term blood pressure and metabolic effects of tibolone in postmenopausal women with non‐insulin dependent diabetes
    Michael D Feher, A. Cox, A. Levy, Philip Mayne, Ariel F. Lant · 1996 · BJOG An International Journal of Obstetrics & Gynaecology
82. Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study
    Giray Kabakçı · 2008 · Integrated Blood Pressure Control
83. Increased Risk of Myocardial Infarction in Men With Both Hypertriglyceridemia and Elevated HDL Cholesterol
    Arnold von Eckardstein, H. Schulte, Gerd Assmann · 1999 · Circulation
84. Clinical Considerations and Mechanistic Determinants of Postprandial Lipemia in Older Adults
    Christos S. Katsanos · 2014 · Advances in Nutrition
85. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease
    Carlo Maria Barbagallo, Manfredi Rizzo, Davide Noto, Arian Frasheri, Vincenzo Pernice, Antonio Rubino, Daniele Pieri, Vito Pinto, Angelo Baldassare Cefalu, Carla Santos de Souza Giordano et al. · 2006 · Metabolism
86. Sex steroids and plasma lipoprotein levels in healthy women: the importance of androgens in the estrogen-deficient state
    André P. van Beek, Florianne C. de Ruijter-Heijstek, Hans Jansen, D.W. Erkelens, Tjerk WA de Bruin · 2004 · Metabolism
87. β-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells
    Masafumi Takahashi, Sadao Takahashi, Masahisa Shimpo, Akitaka Naito, Yukiyo Ogata, Eiji Kobayashi, Uichi Ikeda, Kazuyuki Shimada · 2002 · Atherosclerosis
88. Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women
    Sidika E. Kasim-Karakas, Edward Lane, Rogelio U. Almario, Wendy M. Mueller, Rosemary L. Walzem · 1997 · Metabolism
89. Impairment of Cellular Interactions in the Arterial Wall: Arteriosclerosis
    Victor W.M. van Hinsbergh · 1992 · Annals of the New York Academy of Sciences
90. Specific Increase in Small Dense Low-Density Lipoprotein-Cholesterol Levels beyond Triglycerides in Patients with Diabetes: Implications for Cardiovascular Risk of MAFLD
    Tsutomu Hirano, Noriyuki Satoh, Yasuki Ito · 2023 · Journal of Atherosclerosis and Thrombosis
91. Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus
    Gissette Reyes‐Soffer, Carlos Rondon-Clavo, Henry N. Ginsberg · 2011 · Expert Opinion on Pharmacotherapy
92. Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment
    Chia-Lin Li, Shih‐Tzer Tsai, Pesus Chou · 2002 · Journal of Clinical Epidemiology
93. Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia
    Enzo Manzato, Sabina Zambon, Alberto Zambon, Aldo Cortella, Giovanni Sartore, Gaetano Crepaldi · 1993 · Clinica Chimica Acta
94. Lipoprotein Metabolism in Normal and Uremic Patients
    Ira J. Goldberg · 1993 · American Journal of Kidney Diseases
95. THE ROLE OF CHOLESTEROL MANAGEMENT IN CORONARY DISEASE RISK REDUCTION IN ELDERLY PATIENTS
    Scott M. Grundy · 1998 · Endocrinology and Metabolism Clinics of North America
96. Relationship of triglycerides and HDL cholesterol in hypertriglyceridemia
    Pietro Avogaro, Giancarlo Ghiselli, Stefano Soldan, Gabriele Bittolo Bon · 1992 · Atherosclerosis
97. Abnormal distribution of VLDL subfractions in Type 1 (insulin-dependent) diabetic patients: could plasma lipase activities play a role?
    Lidia Patti, G. Romanò, Luigi Marino, Giovanni Annuzzi, Mario Mancini, Gabriele Riccardi, Angela Albarosa Rivellese · 1993 · Diabetologia
98. Normal postprandial lipemia in men with low plasma HDL concentrations.
    Jonathan C. Cohen, Scott M. Grundy · 1992 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
99. Coronary heart disease
    Julie Anne Lovegrove, Kim G. Jackson · 2000 · Elsevier eBooks
100. An improved reference measurement procedure for triglycerides and total glycerides in human serum by isotope dilution gas chromatography–mass spectrometry
     Yizhao Chen, Qinde Liu, Sharon Yong, Hui Ling Teo, Tong Kooi Lee · 2013 · Clinica Chimica Acta